Telmidrop Tablets 80 mg (Telmisartan)

Adult dose

Essential Hypertension Telmisartan should be taken orally once daily at a dose of 40 mg with water, and it can be taken regardless of meals. In some patients, a dose of 20 mg once daily may be effective. If necessary, the dosage can be increased to 80 mg once daily. When increasing the dosage, the maximal antihypertensive effect typically occurs 4 to 8 weeks after starting treatment. Reduction of Cardiovascular Disease Risk This medication is recommended to be taken orally as 80 mg once daily with water, and it can be taken regardless of meals.

This medication can pose serious risks, especially to the fetus and newborn, during pregnancy, so usage should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with an allergy to this drug, pregnant or breastfeeding women, patients with severe liver disease or bile duct obstruction, patients with hereditary angioedema, and patients with diabetes or severe kidney disease. Caution is advised for elderly patients, those with high serum potassium levels, patients with slightly impaired liver function, patients with valvular heart disease, patients with cardiovascular disease, those with gastrointestinal disease, and patients with renal artery stenosis. While taking this medication, side effects such as infections, hypotension, blood abnormalities, kidney dysfunction, liver dysfunction, allergic reactions, angioedema, hyperkalemia, myalgia, dyspepsia, headache, and dizziness might occur; any symptoms should prompt immediate consultation with a physician. Especially in cases of rapid blood pressure drop or symptoms of fainting or loss of consciousness, immediate treatment is required, and regular monitoring of kidney function and electrolyte levels is important. This medication may enhance the hypotensive effect or affect kidney function when taken with other antihypertensives, so consultations with healthcare professionals are necessary when combining with other medications. Women who are pregnant or planning to become pregnant should not take this medication, and it is advisable for breastfeeding women to avoid this medication as well. The safety and efficacy of this medication have not been established in children under 18 years old; therefore, it is not recommended. Overdose may result in symptoms such as hypotension, dizziness, and acute renal failure, so caution should be taken to avoid exceeding the prescribed dosage, and immediate medical attention should be sought for any abnormal symptoms. This medication should be stored in a place that is out of reach of children, not transferred to another container, and it is recommended to open the package just before use. Special caution is needed during driving or operating dangerous machinery, as blood pressure may drop suddenly.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever with severe rash, blistering, skin peel-off, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities with cough and fever, respiratory issues, yellowing of skin or eyes (jaundice), severe lethargy, liver abnormalities (jaundice), sudden

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hyperkalemia
• hypoglycemia

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be safely preserved.

Appearance

White oval tablet

Package unit

PTP - 30 tablets/box [(10 tablets/Alu-Alu × 3)], PE bottle - 30 tablets/bottle